Administrative Core
Administrative Core
批准号:
10219295
负责人:
Jian-Xing Ma
金额:
$27.68万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-01 至 2023-06-30
关键词:
AchievementAdvisory CommitteesAmericanAmerican Heart AssociationAnimalsAreaCenters of Research ExcellenceClinicalCollaborationsCommunicationCore FacilityDiabetes MellitusEndocrinologyEnsureEnvironmentEvaluationFeesFosteringFoundationsFundingGoalsGrantGrowthHealth SciencesHistologyHumanImage AnalysisIncubatedInfrastructureMedicineMentorsOklahomaPaperPeer ReviewPhasePilot ProjectsPlayPreventionProgress ReportsPublished CommentPublishingRegulationResearchResearch PersonnelResearch Project GrantsResource SharingResourcesRoleSamplingScientistSeriesStrategic PlanningUnited States National Institutes of HealthUniversitiesVertebratesWorkcollegedata sharingdiabetichuman subjectimprovedmeetingsmembermicroscopic imagingmid-career facultyoperationprogramsranpirnaserecruitrepositoryresearch facilitysuccesssymposium
中文摘要
项目总结
糖尿病研究被认为是研究战略中的两个战略领域之一
俄克拉荷马大学健康科学中心(OUHSC)的计划。这一行动的主要目标是
Cobre将增加糖尿病研究人员的临界数量,并改善基础设施
OUHSC的糖尿病研究。我们的长期目标是申请NIH P30糖尿病研究
中心(DRC)。在过去九年的科布雷支持中,我们与哈罗德密切合作
HAMM糖尿病中心,并达到了我们的第一阶段和第二阶段的里程碑。
孵化了8笔NIH R01赠款、2笔R21和来自以下研究基金会的多笔赠款
如美国糖尿病协会和美国心脏协会。《少年》
在科布雷的支持下,调查人员发表了207篇同行评议的论文。其中五个
在科布雷的支持下,初级调查人员已晋升为副教授。在……里面
此外,科布雷还向OUHSC招募了四名由NIH资助的糖尿病研究人员。这个
管理核心在领导Cobre运营方面发挥了核心作用,并为
这些成就。这个核心在第三阶段的主要目标是进一步扩大这些成功
并协助研究中心成为可持续发展的研究设施,由
使用费和机构资源相结合。在第三阶段,行政核心将
继续提供对整个Cobre的集中管理,并协调Cobre活动
以及所有Cobre组件之间的相互作用。行政核心还将促进
糖尿病眼镜蛇与其他眼镜蛇和OUHSC研究中心的互动
在整个俄克拉荷马州。这一核心将为提高糖尿病的研究做出努力
环境和促进糖尿病研究方面的合作。这一核心将促进资源
和数据共享策略,并确保符合人类受试者、脊椎动物和
生物安全法规。这一核心将极大地促进科布雷的不断发展
实现其目标。
英文摘要
PROJECT SUMMARY
Diabetes research is recognized as one of the two strategic areas in the Research Strategic
Plan of The University of Oklahoma Health Sciences Center (OUHSC). The major goal of this
COBRE is to increase the critical mass of diabetes researchers and improve infrastructure for
diabetes research at OUHSC. Our long-term goal is to apply for a NIH P30 Diabetes Research
Center (DRC). In the past nine years of COBRE support, we have closely worked with the Harold
Hamm Diabetes Center and reached our milestones of Phase I and Phase II. The COBRE has
incubated eight NIH R01 grants, two R21s and multiple grants from research foundations such
as the American Diabetes Association and the American Heart Association. The Junior
Investigators supported by the COBRE have published 207 peer-reviewed papers. Five of the
Junior Investigators supported by the COBRE have been promoted to Associate Professors. In
addition, the COBRE has recruited four NIH-funded diabetic researchers into OUHSC. The
Administrative Core has played a central role in leading COBRE operations and contributed to
these achievements. The major goal of this Core in Phase III is to further expand these successes
and assist the research Cores to become sustainable research facilities supported by a
combination of user fees and institutional resources. In Phase III, the Administrative Core will
continue to provide central management of the entire COBRE and coordinate COBRE activities
and interactions among all of the COBRE components. The Administrative Core will also facilitate
interactions of the Diabetes COBRE with other COBREs and research Centers at OUHSC and
throughout the State of Oklahoma. This Core will make an effort to improve the diabetes research
environment and facilitate collaborations in diabetes research. This Core will promote resource
and data sharing strategies and ensure compliance with human subjects, vertebrate animals and
biosafety regulations. This Core will greatly facilitate the continuous growth of the COBRE to
achieve its goals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dysregulation of PPARα in RPE degeneration
-
批准号:10736062
-
项目类别:
-
资助金额:$54.59万
-
财政年份:2023
-
负责人:Jian-Xing Ma
-
依托单位:
Sustained release of fenofibrate for the treatment of diabetic retinopathy
-
批准号:10521702
-
项目类别:
-
资助金额:$55.18万
-
财政年份:2022
-
负责人:Jian-Xing Ma
-
依托单位:
cGAS-STING signaling in diabetic retinopathy
-
批准号:10610331
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2022
-
负责人:Jian-Xing Ma
-
依托单位:
Sustained release of fenofibrate for the treatment of diabetic retinopathy
-
批准号:10684823
-
项目类别:
-
资助金额:$53.8万
-
财政年份:2022
-
负责人:Jian-Xing Ma
-
依托单位:
cGAS-STING signaling in diabetic retinopathy
-
批准号:10339181
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2022
-
负责人:Jian-Xing Ma
-
依托单位:
Studies of retinyl ester hydrolase in the visual cycle
-
批准号:10547900
-
项目类别:
-
资助金额:$31.66万
-
财政年份:2021
-
负责人:Jian-Xing Ma
-
依托单位:
Studies of retinyl ester hydrolase in the visual cycle
-
批准号:10652486
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2021
-
负责人:Jian-Xing Ma
-
依托单位:
Studies of retinyl ester hydrolase in the visual cycle
-
批准号:10278989
-
项目类别:
-
资助金额:$4.59万
-
财政年份:2021
-
负责人:Jian-Xing Ma
-
依托单位:
Studies of retinyl ester hydrolase in the visual cycle
-
批准号:10459611
-
项目类别:
-
资助金额:$37.59万
-
财政年份:2021
-
负责人:Jian-Xing Ma
-
依托单位:
Diabetic Animal Core
-
批准号:10219292
-
项目类别:
-
资助金额:$29.6万
-
财政年份:2017
-
负责人:Jian-Xing Ma
-
依托单位:
Mentoring Diabetes Research in Oklahoma
-
批准号:9281482
-
项目类别:
-
资助金额:$111.0万
-
财政年份:2017
-
负责人:Jian-Xing Ma
-
依托单位:
OKHSC COBRE: DIABETIC ANIMAL CORE
-
批准号:8360275
-
项目类别:
-
资助金额:$31.16万
-
财政年份:2011
-
负责人:Jian-Xing Ma
-
依托单位:
OKHSC COBRE: ADMINISTRATIVE AND MENTORING CORE
-
批准号:8360274
-
项目类别:
-
资助金额:$50.39万
-
财政年份:2011
-
负责人:Jian-Xing Ma
-
依托单位:
OKHSC COBRE: DIABETIC ANIMAL CORE
-
批准号:8167966
-
项目类别:
-
资助金额:$33.11万
-
财政年份:2010
-
负责人:Jian-Xing Ma
-
依托单位:
OKHSC COBRE: ADMINISTRATIVE AND MENTORING CORE
-
批准号:8167965
-
项目类别:
-
资助金额:$52.21万
-
财政年份:2010
-
负责人:Jian-Xing Ma
-
依托单位:
The wnt signaling pathway in choroidal neovascularization
-
批准号:7524829
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2009
-
负责人:Jian-Xing Ma
-
依托单位:
A new pathogenic mechanism for diabetic retinopathy
-
批准号:8503730
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2009
-
负责人:Jian-Xing Ma
-
依托单位:
A new pathogenic mechanism for diabetic retinopathy
-
批准号:7565534
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2009
-
负责人:Jian-Xing Ma
-
依托单位:
The role of the wnt signaling pathway in choroidal neovascularization
-
批准号:8185791
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2009
-
负责人:Jian-Xing Ma
-
依托单位:
A new pathogenic mechanism for diabetic retinopathy
-
批准号:10132322
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Jian-Xing Ma
-
依托单位:
海外基金